+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orphan Drugs Market Report by Drug Type, Disease Type, Phase, Top Selling Drugs, Distribution Channel, and Region 2024-2032

  • PDF Icon

    Report

  • 135 Pages
  • April 2024
  • Region: Global
  • IMARC Group
  • ID: 5547179
Description Jump to:
The global orphan drugs market size reached US$ 214.8 Billion in 2023. Looking forward, the market is projected to reach US$ 541.3 Billion by 2032, exhibiting a growth rate (CAGR) of 10.82% during 2023-2032.

Orphan drugs refer to pharmaceutical products used for the diagnosis, prevention and treatment of rare medical disorders. These drugs are manufactured to meet a specific public health requirement and usually have a limited market as they are produced for a small group of patients. They are effective against numerous oncological, metabolic, hematologic, immunologic, infectious and neurological diseases. Medical ailments, such as lymphoma, leukemia, cystic fibrosis, glioma, pancreatic cancer, ovarian cancer, multiple myeloma and renal cell carcinoma, are often life-threatening, chronic, progressive, degenerative and disabling and require specific treatment alternatives that are effective for their particular symptoms.

Orphan Drugs Market Trends

The increasing prevalence of cancer and other rare genetic disorders is one of the key factors driving the growth of the market. Pharmaceutical manufacturers are developing innovative orphan drugs to provide personalized therapy to patients. The market is also being driven by increasing awareness among the masses regarding the benefits of orphan drugs. The emergence of new pharmaceutical drug manufacturers and the implementation of favorable government policies to inhibit the spread of contagious diseases are also contributing to the market growth.

Additionally, various product innovations, such as the development of biological orphan drugs, are acting as other growth-inducing factors. These drugs can treat diseases, such as cancer, and reverse the damage caused to the stem cells, which is facilitating their overall demand significantly. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are expected to drive the market further.

Key Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts at the global, regional and country levels from 2024-2032. The report has categorized the market based on drug type, disease type, phase, top selling drugs and distribution channel.

Breakup by Drug Type:

  • Biological
  • Non-Biological

Breakup by Disease Type:

  • Oncology
  • Hematology
  • Neurology
  • Cardiovascular
  • Others

Breakup by Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Breakup by Top Selling Drugs:

  • Revlimid
  • Rituxan
  • Copaxone
  • Opdivo
  • Keytruda
  • Imbruvica
  • Avonex
  • Sensipar
  • Soliris
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Alexion Pharmaceuticals Inc., Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG (Roche Holding AG), Jazz Pharmaceuticals Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global orphan drugs market in 2023?
2. What is the expected growth rate of the global orphan drugs market during 2024-2032?
3. What are the key factors driving the global orphan drugs market?
4. What has been the impact of COVID-19 on the global orphan drugs market?
5. What is the breakup of the global orphan drugs market based on the drug type?
6. What is the breakup of the global orphan drugs market based on the disease type?
7. What is the breakup of the global orphan drugs market based on top selling drugs?
8. What is the breakup of the global orphan drugs market based on the distribution channel?
9. What are the key regions in the global orphan drugs market?
10. Who are the key players/companies in the global orphan drugs market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Orphan Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Type
6.1 Biological
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-Biological
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Disease Type
7.1 Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hematology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Phase
8.1 Phase I
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Phase II
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Phase III
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Phase IV
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Top Selling Drugs
9.1 Revlimid
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Rituxan
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Copaxone
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Opdivo
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Keytruda
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Imbruvica
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Avonex
9.7.1 Market Trends
9.7.2 Market Forecast
9.8 Sensipar
9.8.1 Market Trends
9.8.2 Market Forecast
9.9 Soliris
9.9.1 Market Trends
9.9.2 Market Forecast
9.10 Others
9.10.1 Market Trends
9.10.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Stores
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Alexion Pharmaceuticals Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Amgen Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Biogen Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Bristol Myers Squibb Company
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 Jazz Pharmaceuticals Plc
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Johnson & Johnson
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Merck & Co. Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novartis AG
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Pfizer Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Sanofi S.A.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Takeda Pharmaceutical Company Limited
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
16.3.14 Teva Pharmaceutical Industries Ltd
16.3.14.1 Company Overview
16.3.14.2 Product Portfolio
16.3.14.3 Financials
16.3.14.4 SWOT Analysis
List of Figures
Figure 1: Global: Orphan Drugs Market: Major Drivers and Challenges
Figure 2: Global: Orphan Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Orphan Drugs Market: Breakup by Drug Type (in %), 2023
Figure 4: Global: Orphan Drugs Market: Breakup by Disease Type (in %), 2023
Figure 5: Global: Orphan Drugs Market: Breakup by Phase (in %), 2023
Figure 6: Global: Orphan Drugs Market: Breakup by Top Selling Drugs (in %), 2023
Figure 7: Global: Orphan Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Orphan Drugs Market: Breakup by Region (in %), 2023
Figure 9: Global: Orphan Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Orphan Drugs (Biological) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Orphan Drugs (Biological) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Orphan Drugs (Non-Biological) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Orphan Drugs (Non-Biological) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Orphan Drugs (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Orphan Drugs (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Orphan Drugs (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Orphan Drugs (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Orphan Drugs (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Orphan Drugs (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Orphan Drugs (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Orphan Drugs (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Orphan Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Orphan Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Orphan Drugs (Phase I) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Orphan Drugs (Phase I) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Orphan Drugs (Phase II) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Orphan Drugs (Phase II) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Orphan Drugs (Phase III) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Orphan Drugs (Phase III) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Orphan Drugs (Phase IV) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Orphan Drugs (Phase IV) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Orphan Drugs (Revlimid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Orphan Drugs (Revlimid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Orphan Drugs (Rituxan) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Orphan Drugs (Rituxan) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Orphan Drugs (Copaxone) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Orphan Drugs (Copaxone) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Orphan Drugs (Opdivo) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Orphan Drugs (Opdivo) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Orphan Drugs (Keytruda) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Orphan Drugs (Keytruda) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Orphan Drugs (Imbruvica) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Orphan Drugs (Imbruvica) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Orphan Drugs (Avonex) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Orphan Drugs (Avonex) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Global: Orphan Drugs (Sensipar) Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Global: Orphan Drugs (Sensipar) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Global: Orphan Drugs (Soliris) Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Global: Orphan Drugs (Soliris) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Global: Orphan Drugs (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Global: Orphan Drugs (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Global: Orphan Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Global: Orphan Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Global: Orphan Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Global: Orphan Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Global: Orphan Drugs (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Global: Orphan Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Global: Orphan Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Global: Orphan Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: North America: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: North America: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United States: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United States: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Canada: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Canada: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Asia Pacific: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Asia Pacific: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: China: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: China: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Japan: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Japan: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: India: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: India: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: South Korea: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: South Korea: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Australia: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Australia: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Indonesia: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Indonesia: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Europe: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Europe: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Germany: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Germany: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: France: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: France: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: United Kingdom: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: United Kingdom: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Italy: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Italy: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Spain: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Spain: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Russia: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 95: Russia: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Others: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 97: Others: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 98: Latin America: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 99: Latin America: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 100: Brazil: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 101: Brazil: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 102: Mexico: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 103: Mexico: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 104: Others: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 105: Others: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 106: Middle East and Africa: Orphan Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 107: Middle East and Africa: Orphan Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 108: Global: Orphan Drugs Industry: SWOT Analysis
Figure 109: Global: Orphan Drugs Industry: Value Chain Analysis
Figure 110: Global: Orphan Drugs Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Orphan Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Orphan Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 3: Global: Orphan Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
Table 4: Global: Orphan Drugs Market Forecast: Breakup by Phase (in Million US$), 2024-2032
Table 5: Global: Orphan Drugs Market Forecast: Breakup by Top Selling Drugs (in Million US$), 2024-2032
Table 6: Global: Orphan Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 7: Global: Orphan Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Orphan Drugs Market Structure
Table 9: Global: Orphan Drugs Market: Key Players

Companies Mentioned

  • AbbVie Inc.
  • Alexion Pharmaceuticals Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Jazz Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages135
PublishedApril 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 214.8 Billion
Forecasted Market Value ( USD ) by 2032 $ 541.3 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Orphan Drugs Market by Disease Type, Product Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Orphan Drugs Market by Disease Type, Product Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • 409 Pages
  • Global
From
Orphan Drugs Global Market Report 2024 - Product Image

Orphan Drugs Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Orphan Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Orphan Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Orphan Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Orphan Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.